huanglian-jie-du-tang

Botanicalexperimental

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2015 (NCT02467647)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • huang-lian-jie-du
  • huanglianjiedutang
  • huanglian-jie-du-tang
  • huanglian-jie-du-tang
  • huanglianjiedutang decoction
  • oren gedoku to
  • oren-gedoku-to
  • orengedoku-to
  • ouren godoku to
  • tj15
  • tj-15

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06467851N/AAug 31, 2023Nanjing Medical University
NCT05613062Phase 1/Phase 2 (Phase 2)Nov 30, 2022Chinese University of Hong Kong
NCT03469232Phase 1/Phase 2 (Phase 2)Apr 4, 2018China Academy of Chinese Medical Sciences
NCT02467647Phase 1Jan 1, 2015Huazhong University of Science and Technology, Wuhan University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
China Academy of Chinese Medical SciencesAcademic/Hospital1112018
Chinese University of Hong KongAcademic/Hospital1112022
Huazhong University of Science and TechnologyAcademic/Hospital1012015
Nanjing Medical UniversityAcademic/Hospital1112023
Wuhan UniversityAcademic/Hospital1112015
5 organizations
Page 1 / 1